HONG KONG – Although the government has set its sights on advancing personalized medicine in China, most of the existing gene-related technologies are still of foreign origin, so are some of the leading companies operating here. The question at the moment is whether development of precision medicine in the country is a domestic or foreign affair? And where will the huge amount of government funding in the space go?